Page 14 - Nasdaq Podd News Today

Insulet (NASDAQ:PODD – Get Rating) had its price target cut by stock analysts at Morgan Stanley from $268.00 to $244.00 in a report released on Tuesday, Stock Target Advisor reports. The brokerage presently has an “equal weight” rating on the medical instruments supplier’s stock. Morgan Stanley’s target price would indicate a potential upside of 12.05% […]

Equities analysts expect Insulet Co. (NASDAQ:PODD – Get Rating) to report $0.22 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Insulet’s earnings, with the lowest EPS estimate coming in at $0.13 and the highest estimate coming in at $0.39. Insulet reported earnings of $0.10 per […]

Equities research analysts forecast that Insulet Co. (NASDAQ:PODD – Get Rating) will post earnings per share (EPS) of $0.22 for the current quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Insulet’s earnings, with estimates ranging from $0.13 to $0.39. Insulet posted earnings per share of $0.10 in the same quarter last year, […]

Insulet (NASDAQ:PODD – Get Rating) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.17, MarketWatch Earnings reports. The firm had revenue of $295.40 million during the quarter, compared to the consensus estimate of $287.99 million. Insulet had a net […]

Insulet (NASDAQ:PODD – Get Rating) had its price target decreased by Wells Fargo & Company from $357.00 to $345.00 in a research note issued to investors on Friday, The Fly reports. Wells Fargo & Company‘s target price indicates a potential upside of 52.04% from the stock’s previous close. PODD has been the topic of several […]

Analysts expect Insulet Co. (NASDAQ:PODD – Get Rating) to report earnings of $0.23 per share for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have provided estimates for Insulet’s earnings, with estimates ranging from $0.15 to $0.28. The firm is scheduled to report its next earnings report after the market closes on Monday, […]

Wall Street analysts predict that Insulet Co. (NASDAQ:PODD – Get Rating) will announce sales of $286.84 million for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have provided estimates for Insulet’s earnings. The lowest sales estimate is $284.10 million and the highest is $291.00 million. Insulet reported sales of $252.30 million during the […]

Assenagon Asset Management S.A. grew its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 284.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 13,052 shares of the medical instruments supplier’s stock after buying an additional 9,659 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Insulet were worth $3,473,000 as of its […]

Oppenheimer Asset Management Inc. grew its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 0.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 23,622 shares of the medical instruments supplier’s stock after buying an additional 57 shares during the quarter. Oppenheimer […]

Nomura Asset Management Co. Ltd. raised its holdings in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 6.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 73,655 shares of the medical instruments supplier’s stock after acquiring an additional 4,404 shares during the […]